93 results
Page 3 of 5
8-K
EX-99.1
qrs9eeufl635r
17 May 21
Zentalis Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update
7:02am
DEFA14A
ps2q15yo30cv y7
23 Apr 21
Additional proxy soliciting materials
4:06pm
DEF 14A
sznk8z9bkkazbad9uby
23 Apr 21
Definitive proxy
4:05pm
10-K
3xw7le3z
25 Mar 21
Annual report
7:17am
10-K
EX-10.12
vsxgx 9ndeis
25 Mar 21
Annual report
7:17am
8-K
EX-99.1
0wvg 5hqu6fvv3c1lx40
25 Mar 21
Zentalis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
7:04am
8-K
EX-10.4
nfv3qr7211sg340x
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.1
tgyccmmoo
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.2
ifj0igszn viu
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.3
c31ft
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
424B4
o4wyoor 9z0vx0
31 Jul 20
Prospectus supplement with pricing info
12:00am
DRS
EX-10.18
b2n4wb95e2xp3ov5h
10 Jul 20
Draft registration statement
12:00am